| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Brain Neoplasms | 143 | 2025 | 9213 | 5.410 |
Why?
|
| Glioblastoma | 86 | 2025 | 3525 | 5.170 |
Why?
|
| Glioma | 75 | 2025 | 3532 | 4.840 |
Why?
|
| Astrocytoma | 25 | 2023 | 780 | 2.170 |
Why?
|
| Meningioma | 14 | 2022 | 1226 | 1.360 |
Why?
|
| Meningeal Neoplasms | 15 | 2022 | 1258 | 1.360 |
Why?
|
| Oligodendroglia | 12 | 2020 | 540 | 1.280 |
Why?
|
| Mutation | 75 | 2025 | 30266 | 1.120 |
Why?
|
| Isocitrate Dehydrogenase | 20 | 2025 | 958 | 1.110 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 15 | 2019 | 1143 | 1.080 |
Why?
|
| Neoplasm Recurrence, Local | 23 | 2025 | 9442 | 1.000 |
Why?
|
| PTEN Phosphohydrolase | 11 | 2020 | 1120 | 0.980 |
Why?
|
| Central Nervous System Neoplasms | 8 | 2024 | 930 | 0.950 |
Why?
|
| Dacarbazine | 14 | 2022 | 559 | 0.920 |
Why?
|
| DNA Copy Number Variations | 11 | 2022 | 2055 | 0.890 |
Why?
|
| Comparative Genomic Hybridization | 13 | 2017 | 474 | 0.880 |
Why?
|
| Proto-Oncogene Proteins B-raf | 16 | 2024 | 2059 | 0.880 |
Why?
|
| Medulloblastoma | 9 | 2024 | 683 | 0.870 |
Why?
|
| Antineoplastic Agents, Alkylating | 10 | 2022 | 618 | 0.810 |
Why?
|
| Oligodendroglioma | 11 | 2024 | 278 | 0.780 |
Why?
|
| Nerve Tissue Proteins | 12 | 2014 | 4415 | 0.760 |
Why?
|
| Tumor Suppressor Protein p53 | 16 | 2023 | 2960 | 0.730 |
Why?
|
| Single-Cell Analysis | 12 | 2024 | 2542 | 0.730 |
Why?
|
| Aminopyridines | 4 | 2019 | 580 | 0.690 |
Why?
|
| Morpholines | 4 | 2019 | 584 | 0.660 |
Why?
|
| Cerebellar Neoplasms | 6 | 2024 | 591 | 0.650 |
Why?
|
| Oncogene Proteins, Fusion | 11 | 2022 | 1616 | 0.650 |
Why?
|
| Phosphatidylinositol 3-Kinase | 2 | 2023 | 126 | 0.650 |
Why?
|
| High-Throughput Nucleotide Sequencing | 18 | 2024 | 3671 | 0.640 |
Why?
|
| Neural Stem Cells | 7 | 2020 | 895 | 0.630 |
Why?
|
| Pineal Gland | 4 | 2019 | 158 | 0.630 |
Why?
|
| Brain Stem Neoplasms | 6 | 2022 | 191 | 0.590 |
Why?
|
| Genomics | 19 | 2024 | 5928 | 0.580 |
Why?
|
| Antineoplastic Agents | 19 | 2023 | 13699 | 0.580 |
Why?
|
| Homeodomain Proteins | 7 | 2017 | 2431 | 0.570 |
Why?
|
| Cell Lineage | 17 | 2024 | 2576 | 0.570 |
Why?
|
| Gene Expression Regulation, Neoplastic | 28 | 2024 | 8664 | 0.560 |
Why?
|
| Stem Cells | 9 | 2014 | 3540 | 0.550 |
Why?
|
| Trans-Activators | 4 | 2019 | 2858 | 0.550 |
Why?
|
| Oncogenes | 10 | 2022 | 1236 | 0.540 |
Why?
|
| Neoplasms, Neuroepithelial | 1 | 2016 | 43 | 0.530 |
Why?
|
| Histones | 12 | 2023 | 2603 | 0.520 |
Why?
|
| Phosphatidylinositol 3-Kinases | 8 | 2023 | 2884 | 0.520 |
Why?
|
| Hedgehog Proteins | 5 | 2015 | 771 | 0.520 |
Why?
|
| Central Nervous System | 5 | 2022 | 1345 | 0.510 |
Why?
|
| Humans | 258 | 2025 | 768887 | 0.490 |
Why?
|
| Proto-Oncogene Proteins | 8 | 2022 | 4528 | 0.460 |
Why?
|
| Cell Line, Tumor | 39 | 2024 | 17174 | 0.460 |
Why?
|
| Mice | 72 | 2024 | 82074 | 0.460 |
Why?
|
| Germinoma | 2 | 2022 | 132 | 0.450 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 9 | 2020 | 710 | 0.440 |
Why?
|
| DNA Methylation | 15 | 2023 | 4432 | 0.430 |
Why?
|
| Pinealoma | 3 | 2019 | 52 | 0.430 |
Why?
|
| Astrocytes | 12 | 2024 | 1349 | 0.420 |
Why?
|
| Molecular Targeted Therapy | 8 | 2024 | 2830 | 0.420 |
Why?
|
| Cell Transformation, Neoplastic | 11 | 2023 | 2848 | 0.410 |
Why?
|
| Rhabdoid Tumor | 3 | 2024 | 211 | 0.400 |
Why?
|
| Sequence Analysis, DNA | 10 | 2020 | 4784 | 0.400 |
Why?
|
| Receptor, trkB | 3 | 2020 | 125 | 0.390 |
Why?
|
| Child | 61 | 2025 | 80969 | 0.390 |
Why?
|
| Animals | 87 | 2024 | 169408 | 0.390 |
Why?
|
| Chromosomes, Human, Pair 1 | 6 | 2019 | 640 | 0.390 |
Why?
|
| Genome, Human | 10 | 2020 | 4456 | 0.390 |
Why?
|
| Neoadjuvant Therapy | 2 | 2024 | 2909 | 0.390 |
Why?
|
| Gene Expression Regulation, Developmental | 9 | 2020 | 3613 | 0.380 |
Why?
|
| DNA Modification Methylases | 7 | 2022 | 210 | 0.380 |
Why?
|
| Triazoles | 4 | 2024 | 904 | 0.380 |
Why?
|
| Glutarates | 5 | 2023 | 243 | 0.370 |
Why?
|
| Cell Differentiation | 18 | 2024 | 11684 | 0.360 |
Why?
|
| Prognosis | 35 | 2025 | 30044 | 0.360 |
Why?
|
| Ependymoma | 3 | 2020 | 328 | 0.340 |
Why?
|
| Gene Expression Profiling | 22 | 2021 | 9549 | 0.340 |
Why?
|
| Neurons | 10 | 2020 | 9524 | 0.340 |
Why?
|
| Forkhead Transcription Factors | 4 | 2022 | 1625 | 0.330 |
Why?
|
| Angiomatosis | 1 | 2009 | 46 | 0.320 |
Why?
|
| DNA Repair Enzymes | 6 | 2022 | 346 | 0.320 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 10 | 2018 | 11886 | 0.310 |
Why?
|
| Tumor Suppressor Proteins | 9 | 2022 | 2813 | 0.310 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 6 | 2017 | 4593 | 0.310 |
Why?
|
| Hydrazines | 2 | 2024 | 223 | 0.310 |
Why?
|
| Drug Resistance, Neoplasm | 10 | 2019 | 5342 | 0.310 |
Why?
|
| DNA Mutational Analysis | 11 | 2021 | 4123 | 0.310 |
Why?
|
| Male | 105 | 2025 | 365249 | 0.300 |
Why?
|
| Proto-Oncogene Proteins c-myb | 2 | 2019 | 82 | 0.300 |
Why?
|
| Receptor, Platelet-Derived Growth Factor alpha | 4 | 2020 | 368 | 0.300 |
Why?
|
| Gene Dosage | 6 | 2020 | 1222 | 0.290 |
Why?
|
| Retinal Neoplasms | 1 | 2009 | 151 | 0.290 |
Why?
|
| Xenograft Model Antitumor Assays | 11 | 2023 | 3621 | 0.290 |
Why?
|
| Mice, Nude | 12 | 2019 | 3631 | 0.280 |
Why?
|
| Retinoblastoma Protein | 1 | 2011 | 673 | 0.280 |
Why?
|
| Glycoproteins | 2 | 2014 | 2202 | 0.280 |
Why?
|
| Genome-Wide Association Study | 4 | 2017 | 12798 | 0.280 |
Why?
|
| Female | 103 | 2025 | 397464 | 0.270 |
Why?
|
| Cell Proliferation | 20 | 2024 | 10486 | 0.270 |
Why?
|
| Immunotherapy | 4 | 2024 | 4755 | 0.270 |
Why?
|
| Child, Preschool | 28 | 2025 | 42684 | 0.270 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 3 | 2013 | 267 | 0.260 |
Why?
|
| Adult | 66 | 2025 | 223818 | 0.260 |
Why?
|
| Mi-2 Nucleosome Remodeling and Deacetylase Complex | 2 | 2019 | 117 | 0.260 |
Why?
|
| Neoplasms | 10 | 2024 | 22390 | 0.260 |
Why?
|
| Signal Transduction | 23 | 2020 | 23652 | 0.250 |
Why?
|
| Telomerase | 3 | 2023 | 753 | 0.250 |
Why?
|
| Pituitary Neoplasms | 4 | 2017 | 1326 | 0.250 |
Why?
|
| Survival Rate | 16 | 2025 | 12873 | 0.250 |
Why?
|
| Neoplastic Stem Cells | 5 | 2022 | 1356 | 0.240 |
Why?
|
| Neoplasms, Experimental | 5 | 2020 | 1231 | 0.240 |
Why?
|
| Adolescent | 40 | 2025 | 89247 | 0.240 |
Why?
|
| Tumor Microenvironment | 11 | 2023 | 3951 | 0.230 |
Why?
|
| Antigens, CD | 2 | 2014 | 4032 | 0.230 |
Why?
|
| RNA-Binding Proteins | 4 | 2017 | 1891 | 0.230 |
Why?
|
| Transcription Factors | 14 | 2024 | 12174 | 0.230 |
Why?
|
| Gene Fusion | 2 | 2017 | 357 | 0.220 |
Why?
|
| Middle Aged | 57 | 2025 | 223740 | 0.220 |
Why?
|
| Histocytochemistry | 1 | 2024 | 699 | 0.220 |
Why?
|
| Quinazolines | 4 | 2015 | 1373 | 0.210 |
Why?
|
| Aneuploidy | 2 | 2021 | 573 | 0.210 |
Why?
|
| Indoles | 4 | 2015 | 1836 | 0.210 |
Why?
|
| Proteoglycans | 1 | 2006 | 809 | 0.210 |
Why?
|
| Craniopharyngioma | 2 | 2017 | 279 | 0.210 |
Why?
|
| Interneurons | 2 | 2020 | 593 | 0.210 |
Why?
|
| Embryo, Mammalian | 7 | 2020 | 1676 | 0.210 |
Why?
|
| Aged | 49 | 2025 | 171790 | 0.210 |
Why?
|
| Telencephalon | 1 | 2003 | 142 | 0.200 |
Why?
|
| Retrospective Studies | 32 | 2025 | 81892 | 0.200 |
Why?
|
| Protein Kinase Inhibitors | 5 | 2023 | 5707 | 0.200 |
Why?
|
| Vaccinia | 1 | 2022 | 71 | 0.200 |
Why?
|
| Ribonuclease III | 2 | 2022 | 271 | 0.200 |
Why?
|
| Neuroblastoma | 2 | 2022 | 1266 | 0.200 |
Why?
|
| Microfluidic Analytical Techniques | 2 | 2018 | 823 | 0.200 |
Why?
|
| Choriocarcinoma | 1 | 2022 | 121 | 0.200 |
Why?
|
| Piperidines | 3 | 2018 | 1669 | 0.200 |
Why?
|
| Cell Cycle | 6 | 2022 | 2937 | 0.190 |
Why?
|
| Gliosarcoma | 1 | 2022 | 115 | 0.190 |
Why?
|
| Epigenomics | 3 | 2023 | 961 | 0.190 |
Why?
|
| Magnetic Resonance Imaging | 19 | 2025 | 36861 | 0.190 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 2 | 2022 | 493 | 0.190 |
Why?
|
| Cerebrum | 3 | 2016 | 132 | 0.190 |
Why?
|
| Choristoma | 1 | 2003 | 205 | 0.190 |
Why?
|
| Meninges | 1 | 2003 | 197 | 0.190 |
Why?
|
| Young Adult | 28 | 2025 | 60110 | 0.190 |
Why?
|
| In Situ Hybridization | 4 | 2014 | 1904 | 0.190 |
Why?
|
| Wilms Tumor | 1 | 2024 | 378 | 0.180 |
Why?
|
| DEAD-box RNA Helicases | 2 | 2022 | 385 | 0.180 |
Why?
|
| Infant | 21 | 2025 | 36541 | 0.180 |
Why?
|
| MAP Kinase Signaling System | 4 | 2019 | 1494 | 0.180 |
Why?
|
| NK Cell Lectin-Like Receptor Subfamily B | 1 | 2021 | 85 | 0.180 |
Why?
|
| Transducin | 1 | 2020 | 42 | 0.180 |
Why?
|
| In Situ Hybridization, Fluorescence | 8 | 2019 | 2525 | 0.180 |
Why?
|
| Sarcoma | 3 | 2022 | 1806 | 0.180 |
Why?
|
| Multigene Family | 3 | 2013 | 1082 | 0.180 |
Why?
|
| Neurogenesis | 3 | 2019 | 865 | 0.180 |
Why?
|
| Pathology, Clinical | 1 | 2024 | 377 | 0.180 |
Why?
|
| Antigens | 1 | 2006 | 1444 | 0.180 |
Why?
|
| Clinical Trials as Topic | 6 | 2024 | 8055 | 0.180 |
Why?
|
| SOXB1 Transcription Factors | 3 | 2014 | 286 | 0.180 |
Why?
|
| DNA Mismatch Repair | 2 | 2021 | 432 | 0.180 |
Why?
|
| Pathology, Molecular | 2 | 2022 | 329 | 0.180 |
Why?
|
| Lymphopenia | 1 | 2022 | 299 | 0.170 |
Why?
|
| Epigenesis, Genetic | 8 | 2022 | 3836 | 0.170 |
Why?
|
| MicroRNAs | 4 | 2019 | 3811 | 0.170 |
Why?
|
| Brain | 12 | 2022 | 27476 | 0.170 |
Why?
|
| Cell Cycle Proteins | 7 | 2024 | 3450 | 0.170 |
Why?
|
| Brain Edema | 2 | 2020 | 607 | 0.170 |
Why?
|
| Molecular Diagnostic Techniques | 3 | 2020 | 620 | 0.170 |
Why?
|
| Follow-Up Studies | 18 | 2025 | 39394 | 0.170 |
Why?
|
| Immunohistochemistry | 16 | 2020 | 11119 | 0.170 |
Why?
|
| Karyopherins | 2 | 2024 | 134 | 0.170 |
Why?
|
| Neuroglia | 2 | 2019 | 960 | 0.170 |
Why?
|
| Spinal Cord | 4 | 2016 | 1813 | 0.170 |
Why?
|
| Cell Size | 1 | 2021 | 626 | 0.170 |
Why?
|
| Oncolytic Viruses | 1 | 2023 | 345 | 0.160 |
Why?
|
| Receptor, Platelet-Derived Growth Factor beta | 2 | 2018 | 183 | 0.160 |
Why?
|
| DNA Damage | 4 | 2022 | 2472 | 0.160 |
Why?
|
| Angiogenesis Inhibitors | 4 | 2019 | 2059 | 0.160 |
Why?
|
| Chromosome Deletion | 3 | 2015 | 1390 | 0.160 |
Why?
|
| DNA-Binding Proteins | 6 | 2012 | 9618 | 0.160 |
Why?
|
| Nitriles | 1 | 2024 | 990 | 0.160 |
Why?
|
| Zebrafish Proteins | 3 | 2012 | 1019 | 0.160 |
Why?
|
| Pyridones | 1 | 2024 | 819 | 0.160 |
Why?
|
| Glucose-6-Phosphate Isomerase | 1 | 2018 | 49 | 0.160 |
Why?
|
| Aged, 80 and over | 22 | 2021 | 59738 | 0.160 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 2 | 2021 | 906 | 0.160 |
Why?
|
| Protein Folding | 1 | 2023 | 871 | 0.160 |
Why?
|
| Testicular Neoplasms | 3 | 2015 | 805 | 0.160 |
Why?
|
| Kaplan-Meier Estimate | 10 | 2021 | 6546 | 0.160 |
Why?
|
| Dictionaries as Topic | 1 | 2018 | 11 | 0.160 |
Why?
|
| Treatment Outcome | 23 | 2025 | 65485 | 0.160 |
Why?
|
| Cell Enlargement | 1 | 2018 | 59 | 0.160 |
Why?
|
| Active Transport, Cell Nucleus | 2 | 2024 | 432 | 0.160 |
Why?
|
| Ganglioglioma | 1 | 2018 | 36 | 0.160 |
Why?
|
| Retina | 1 | 2009 | 2661 | 0.160 |
Why?
|
| Survival Analysis | 10 | 2023 | 10115 | 0.160 |
Why?
|
| Pyrroles | 2 | 2015 | 1126 | 0.160 |
Why?
|
| Protein Tyrosine Phosphatases, Non-Receptor | 1 | 2018 | 69 | 0.150 |
Why?
|
| E1A-Associated p300 Protein | 1 | 2019 | 125 | 0.150 |
Why?
|
| Ubiquitin Thiolesterase | 2 | 2024 | 465 | 0.150 |
Why?
|
| Carcinoma, Medullary | 1 | 2019 | 116 | 0.150 |
Why?
|
| Drug Screening Assays, Antitumor | 2 | 2021 | 719 | 0.150 |
Why?
|
| Dexamethasone | 3 | 2020 | 1965 | 0.150 |
Why?
|
| Rad51 Recombinase | 1 | 2019 | 191 | 0.150 |
Why?
|
| Stathmin | 1 | 2018 | 70 | 0.150 |
Why?
|
| Autopsy | 2 | 2019 | 1013 | 0.150 |
Why?
|
| Choroid Plexus Neoplasms | 2 | 2016 | 38 | 0.150 |
Why?
|
| Pattern Recognition, Automated | 1 | 2024 | 998 | 0.150 |
Why?
|
| Alleles | 5 | 2019 | 6901 | 0.150 |
Why?
|
| Mutagenesis | 2 | 2020 | 1229 | 0.150 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 2 | 2022 | 362 | 0.150 |
Why?
|
| Neoplasm Transplantation | 6 | 2019 | 2018 | 0.150 |
Why?
|
| Herpesvirus 1, Human | 1 | 2023 | 744 | 0.150 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p18 | 2 | 2008 | 53 | 0.150 |
Why?
|
| Apoptosis | 10 | 2024 | 9528 | 0.150 |
Why?
|
| Epilepsy | 3 | 2024 | 3326 | 0.150 |
Why?
|
| Oncolytic Virotherapy | 1 | 2023 | 521 | 0.150 |
Why?
|
| Transaminases | 1 | 2018 | 199 | 0.150 |
Why?
|
| Microsatellite Repeats | 1 | 2020 | 785 | 0.150 |
Why?
|
| Polymorphism, Single Nucleotide | 8 | 2021 | 16051 | 0.150 |
Why?
|
| Pyridazines | 1 | 2019 | 203 | 0.150 |
Why?
|
| Databases, Protein | 1 | 2019 | 390 | 0.140 |
Why?
|
| Sequence Analysis, RNA | 3 | 2020 | 2041 | 0.140 |
Why?
|
| Cell Survival | 9 | 2024 | 5794 | 0.140 |
Why?
|
| Intranuclear Inclusion Bodies | 1 | 2017 | 34 | 0.140 |
Why?
|
| Seizures | 5 | 2024 | 3000 | 0.140 |
Why?
|
| Cyclin G1 | 1 | 2017 | 15 | 0.140 |
Why?
|
| Methionine | 2 | 2022 | 573 | 0.140 |
Why?
|
| Activin Receptors, Type I | 2 | 2016 | 134 | 0.140 |
Why?
|
| Azepines | 1 | 2019 | 329 | 0.140 |
Why?
|
| Chromatin | 4 | 2022 | 2981 | 0.140 |
Why?
|
| Azetidines | 1 | 2018 | 152 | 0.140 |
Why?
|
| Proteostasis Deficiencies | 1 | 2017 | 39 | 0.140 |
Why?
|
| Mice, Transgenic | 9 | 2020 | 9564 | 0.140 |
Why?
|
| Chromosomes, Human, Pair 19 | 3 | 2019 | 350 | 0.140 |
Why?
|
| raf Kinases | 1 | 2017 | 117 | 0.140 |
Why?
|
| Vinblastine | 1 | 2018 | 487 | 0.140 |
Why?
|
| Disease Progression | 10 | 2021 | 13677 | 0.140 |
Why?
|
| Heterocyclic Compounds, 3-Ring | 2 | 2017 | 296 | 0.140 |
Why?
|
| Interleukin-12 | 1 | 2019 | 577 | 0.140 |
Why?
|
| Micro-Electrical-Mechanical Systems | 1 | 2016 | 30 | 0.140 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 2 | 2019 | 259 | 0.140 |
Why?
|
| Myelin Sheath | 3 | 2012 | 653 | 0.140 |
Why?
|
| Cohort Studies | 17 | 2024 | 41800 | 0.140 |
Why?
|
| Mice, Inbred C57BL | 8 | 2020 | 22381 | 0.130 |
Why?
|
| ADP-Ribosylation Factor 1 | 1 | 2016 | 43 | 0.130 |
Why?
|
| Repressor Proteins | 2 | 2019 | 2986 | 0.130 |
Why?
|
| Nuclear Proteins | 7 | 2024 | 5803 | 0.130 |
Why?
|
| Myxoma | 1 | 2017 | 114 | 0.130 |
Why?
|
| Genes, p53 | 2 | 2009 | 716 | 0.130 |
Why?
|
| Enzyme Activation | 3 | 2019 | 3588 | 0.130 |
Why?
|
| Class Ia Phosphatidylinositol 3-Kinase | 2 | 2016 | 77 | 0.130 |
Why?
|
| Translocation, Genetic | 2 | 2015 | 1395 | 0.130 |
Why?
|
| Oncogene Proteins v-myb | 1 | 2016 | 26 | 0.130 |
Why?
|
| Immunoconjugates | 1 | 2024 | 976 | 0.130 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 3 | 2021 | 1105 | 0.130 |
Why?
|
| Imidazolines | 1 | 2015 | 18 | 0.130 |
Why?
|
| Glutamic Acid | 2 | 2019 | 1193 | 0.130 |
Why?
|
| Metformin | 1 | 2023 | 909 | 0.130 |
Why?
|
| Neoplasm Invasiveness | 4 | 2018 | 3629 | 0.130 |
Why?
|
| Proteasome Endopeptidase Complex | 2 | 2019 | 1320 | 0.130 |
Why?
|
| Information Dissemination | 1 | 2024 | 1141 | 0.130 |
Why?
|
| Proto-Oncogene Proteins c-akt | 3 | 2016 | 2460 | 0.130 |
Why?
|
| Medical Tourism | 1 | 2016 | 51 | 0.130 |
Why?
|
| Receptors, G-Protein-Coupled | 3 | 2017 | 1248 | 0.130 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 2 | 2024 | 859 | 0.130 |
Why?
|
| Histone Deacetylase Inhibitors | 2 | 2018 | 778 | 0.130 |
Why?
|
| Protein Isoforms | 1 | 2020 | 1714 | 0.130 |
Why?
|
| STAT6 Transcription Factor | 1 | 2016 | 196 | 0.130 |
Why?
|
| Promoter Regions, Genetic | 9 | 2021 | 5801 | 0.130 |
Why?
|
| Olfaction Disorders | 1 | 2018 | 225 | 0.130 |
Why?
|
| RNA-Binding Protein EWS | 1 | 2017 | 211 | 0.130 |
Why?
|
| Radiation-Sensitizing Agents | 2 | 2018 | 349 | 0.120 |
Why?
|
| Synteny | 1 | 2015 | 77 | 0.120 |
Why?
|
| Tissue Distribution | 3 | 2015 | 2299 | 0.120 |
Why?
|
| Peptides | 2 | 2019 | 4353 | 0.120 |
Why?
|
| Glycine Hydroxymethyltransferase | 1 | 2015 | 34 | 0.120 |
Why?
|
| Cell Growth Processes | 2 | 2014 | 381 | 0.120 |
Why?
|
| Receptors, Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2015 | 115 | 0.120 |
Why?
|
| Gossypol | 1 | 2014 | 23 | 0.120 |
Why?
|
| Neoplasm Proteins | 3 | 2015 | 3608 | 0.120 |
Why?
|
| Hyperglycemia | 1 | 2023 | 1389 | 0.120 |
Why?
|
| Tumor Cells, Cultured | 6 | 2019 | 6131 | 0.120 |
Why?
|
| Kidney Neoplasms | 2 | 2024 | 4300 | 0.120 |
Why?
|
| Cells, Cultured | 13 | 2018 | 19023 | 0.120 |
Why?
|
| Interferon-gamma | 2 | 2020 | 3163 | 0.120 |
Why?
|
| Glial Fibrillary Acidic Protein | 4 | 2012 | 564 | 0.120 |
Why?
|
| Oxadiazoles | 1 | 2014 | 94 | 0.120 |
Why?
|
| Adenoma, Oxyphilic | 1 | 2016 | 152 | 0.120 |
Why?
|
| Cell Nucleus | 3 | 2017 | 2885 | 0.120 |
Why?
|
| Combined Modality Therapy | 8 | 2025 | 8559 | 0.120 |
Why?
|
| GTPase-Activating Proteins | 1 | 2017 | 469 | 0.120 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2017 | 501 | 0.120 |
Why?
|
| Point Mutation | 2 | 2017 | 1595 | 0.120 |
Why?
|
| Antigens, Neoplasm | 2 | 2021 | 2001 | 0.120 |
Why?
|
| T-Lymphocytes | 3 | 2023 | 10276 | 0.120 |
Why?
|
| Loss of Heterozygosity | 2 | 2014 | 663 | 0.110 |
Why?
|
| Neoplasm Staging | 9 | 2015 | 11262 | 0.110 |
Why?
|
| Leukemia | 1 | 2022 | 1520 | 0.110 |
Why?
|
| DNA Helicases | 4 | 2024 | 854 | 0.110 |
Why?
|
| Software | 2 | 2021 | 4480 | 0.110 |
Why?
|
| Enhancer Elements, Genetic | 3 | 2013 | 1369 | 0.110 |
Why?
|
| Histone Deacetylases | 1 | 2018 | 718 | 0.110 |
Why?
|
| Pharmaceutical Preparations | 1 | 2022 | 1088 | 0.110 |
Why?
|
| Algorithms | 7 | 2019 | 14199 | 0.110 |
Why?
|
| Imidazoles | 1 | 2019 | 1169 | 0.110 |
Why?
|
| Organ Culture Techniques | 1 | 2015 | 796 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 2014 | 387 | 0.110 |
Why?
|
| Octamer Transcription Factor-3 | 3 | 2014 | 221 | 0.110 |
Why?
|
| Disease Models, Animal | 11 | 2022 | 18366 | 0.110 |
Why?
|
| Epitopes | 1 | 2019 | 2529 | 0.110 |
Why?
|
| Connexin 43 | 1 | 2014 | 202 | 0.110 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2019 | 1363 | 0.110 |
Why?
|
| Disease-Free Survival | 8 | 2016 | 6856 | 0.110 |
Why?
|
| Neoplasm, Residual | 1 | 2018 | 1019 | 0.110 |
Why?
|
| Gene Deletion | 4 | 2015 | 2674 | 0.110 |
Why?
|
| Gene Frequency | 1 | 2020 | 3625 | 0.100 |
Why?
|
| Precancerous Conditions | 1 | 2020 | 985 | 0.100 |
Why?
|
| Gene Amplification | 2 | 2014 | 1099 | 0.100 |
Why?
|
| Chemotherapy, Adjuvant | 2 | 2019 | 3554 | 0.100 |
Why?
|
| Acrylamides | 1 | 2014 | 261 | 0.100 |
Why?
|
| Genes, Duplicate | 1 | 2012 | 31 | 0.100 |
Why?
|
| Immunoenzyme Techniques | 6 | 2015 | 1705 | 0.100 |
Why?
|
| Somatostatin | 1 | 2014 | 458 | 0.100 |
Why?
|
| Optic Nerve Glioma | 1 | 2012 | 32 | 0.100 |
Why?
|
| bcl-2 Homologous Antagonist-Killer Protein | 1 | 2012 | 71 | 0.100 |
Why?
|
| Karnofsky Performance Status | 3 | 2019 | 167 | 0.100 |
Why?
|
| Models, Biological | 5 | 2021 | 9499 | 0.100 |
Why?
|
| Decision Trees | 1 | 2014 | 509 | 0.100 |
Why?
|
| Genes, Neurofibromatosis 1 | 1 | 2012 | 74 | 0.100 |
Why?
|
| Protein Multimerization | 1 | 2017 | 968 | 0.100 |
Why?
|
| Lab-On-A-Chip Devices | 1 | 2016 | 446 | 0.100 |
Why?
|
| Mass Spectrometry | 3 | 2014 | 2204 | 0.100 |
Why?
|
| Hydroxamic Acids | 1 | 2015 | 483 | 0.100 |
Why?
|
| Procollagen-Proline Dioxygenase | 1 | 2012 | 81 | 0.100 |
Why?
|
| DNA Fragmentation | 1 | 2012 | 240 | 0.100 |
Why?
|
| Postoperative Care | 1 | 2018 | 1481 | 0.100 |
Why?
|
| Coculture Techniques | 1 | 2015 | 1342 | 0.100 |
Why?
|
| Phenotype | 5 | 2020 | 16735 | 0.100 |
Why?
|
| Immunomodulation | 1 | 2015 | 549 | 0.100 |
Why?
|
| Reproducibility of Results | 10 | 2024 | 20244 | 0.100 |
Why?
|
| Mice, SCID | 4 | 2016 | 2631 | 0.100 |
Why?
|
| Glycine | 1 | 2015 | 672 | 0.090 |
Why?
|
| 3T3 Cells | 1 | 2013 | 1085 | 0.090 |
Why?
|
| Cluster Analysis | 6 | 2019 | 2730 | 0.090 |
Why?
|
| Spectrum Analysis, Raman | 1 | 2013 | 253 | 0.090 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2012 | 282 | 0.090 |
Why?
|
| Phosphorylation | 7 | 2018 | 8317 | 0.090 |
Why?
|
| Cancer Vaccines | 1 | 2018 | 1042 | 0.090 |
Why?
|
| Genotype | 6 | 2016 | 13048 | 0.090 |
Why?
|
| Salvage Therapy | 1 | 2017 | 1277 | 0.090 |
Why?
|
| Trisomy | 1 | 2012 | 260 | 0.090 |
Why?
|
| Lysine | 3 | 2020 | 1000 | 0.090 |
Why?
|
| Cyclin-Dependent Kinase 6 | 2 | 2019 | 354 | 0.090 |
Why?
|
| Parietal Lobe | 1 | 2016 | 866 | 0.090 |
Why?
|
| Breast Neoplasms | 4 | 2024 | 21187 | 0.090 |
Why?
|
| Multipotent Stem Cells | 2 | 2009 | 201 | 0.090 |
Why?
|
| Cell Line | 9 | 2019 | 15603 | 0.090 |
Why?
|
| Neurofibromatosis 1 | 2 | 2012 | 561 | 0.090 |
Why?
|
| Genetic Loci | 2 | 2019 | 2630 | 0.090 |
Why?
|
| Intraoperative Care | 1 | 2014 | 771 | 0.090 |
Why?
|
| Paraffin Embedding | 1 | 2011 | 306 | 0.090 |
Why?
|
| HMGB Proteins | 2 | 2007 | 45 | 0.090 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 5 | 2015 | 3811 | 0.090 |
Why?
|
| Models, Genetic | 2 | 2011 | 3446 | 0.090 |
Why?
|
| Predictive Value of Tests | 8 | 2021 | 15471 | 0.090 |
Why?
|
| Receptors, Cell Surface | 2 | 2021 | 2820 | 0.090 |
Why?
|
| TOR Serine-Threonine Kinases | 2 | 2016 | 2063 | 0.090 |
Why?
|
| Malformations of Cortical Development | 1 | 2012 | 176 | 0.090 |
Why?
|
| Chromosome Aberrations | 2 | 2014 | 1780 | 0.090 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 2 | 2011 | 379 | 0.090 |
Why?
|
| Enzyme Inhibitors | 3 | 2022 | 3724 | 0.080 |
Why?
|
| Formaldehyde | 1 | 2011 | 361 | 0.080 |
Why?
|
| Multiprotein Complexes | 1 | 2016 | 1111 | 0.080 |
Why?
|
| Diagnosis, Differential | 8 | 2018 | 13020 | 0.080 |
Why?
|
| Proteome | 1 | 2019 | 1891 | 0.080 |
Why?
|
| Base Sequence | 9 | 2014 | 12430 | 0.080 |
Why?
|
| NF-kappa B | 1 | 2018 | 2492 | 0.080 |
Why?
|
| Autoantigens | 1 | 2014 | 891 | 0.080 |
Why?
|
| Dioxygenases | 1 | 2012 | 352 | 0.080 |
Why?
|
| Mice, Inbred NOD | 3 | 2020 | 1839 | 0.080 |
Why?
|
| Neuronavigation | 1 | 2011 | 169 | 0.080 |
Why?
|
| Stomach Neoplasms | 1 | 2020 | 1483 | 0.080 |
Why?
|
| Heat-Shock Response | 2 | 2023 | 179 | 0.080 |
Why?
|
| DNA Transposable Elements | 1 | 2013 | 764 | 0.080 |
Why?
|
| Gene Expression Regulation | 5 | 2019 | 11934 | 0.080 |
Why?
|
| Receptor, TIE-2 | 2 | 2019 | 182 | 0.080 |
Why?
|
| Statistics as Topic | 1 | 2015 | 2359 | 0.080 |
Why?
|
| Mice, Knockout | 6 | 2020 | 14485 | 0.080 |
Why?
|
| CpG Islands | 1 | 2013 | 1210 | 0.080 |
Why?
|
| Tumor Burden | 3 | 2023 | 1913 | 0.080 |
Why?
|
| Transforming Growth Factor beta | 1 | 2016 | 2004 | 0.080 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2016 | 1966 | 0.080 |
Why?
|
| Histone Demethylases | 2 | 2023 | 328 | 0.080 |
Why?
|
| Microscopy | 1 | 2013 | 909 | 0.080 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2016 | 1769 | 0.080 |
Why?
|
| Cytokines | 3 | 2019 | 7453 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-ets | 2 | 2022 | 314 | 0.070 |
Why?
|
| Pyrimidines | 3 | 2022 | 3050 | 0.070 |
Why?
|
| Stem Cell Transplantation | 1 | 2016 | 1602 | 0.070 |
Why?
|
| Electroencephalography | 2 | 2022 | 6318 | 0.070 |
Why?
|
| Image Enhancement | 1 | 2018 | 2898 | 0.070 |
Why?
|
| Genes, myc | 1 | 2009 | 391 | 0.070 |
Why?
|
| Medical Oncology | 1 | 2019 | 2350 | 0.070 |
Why?
|
| Microvessels | 1 | 2012 | 586 | 0.070 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2023 | 3626 | 0.070 |
Why?
|
| Embryonic Development | 1 | 2012 | 724 | 0.070 |
Why?
|
| Crosses, Genetic | 1 | 2008 | 752 | 0.070 |
Why?
|
| Diacylglycerol Kinase | 1 | 2007 | 47 | 0.070 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2012 | 724 | 0.070 |
Why?
|
| Helix-Loop-Helix Motifs | 3 | 1996 | 97 | 0.070 |
Why?
|
| Thiazoles | 1 | 2014 | 1542 | 0.070 |
Why?
|
| RNA, Messenger | 5 | 2017 | 12809 | 0.070 |
Why?
|
| Genetic Predisposition to Disease | 6 | 2016 | 18065 | 0.070 |
Why?
|
| Green Fluorescent Proteins | 3 | 2010 | 2067 | 0.070 |
Why?
|
| Drug Design | 1 | 2012 | 1046 | 0.070 |
Why?
|
| GTP-Binding Proteins | 1 | 2011 | 947 | 0.070 |
Why?
|
| Zebrafish | 2 | 2023 | 3037 | 0.070 |
Why?
|
| Polymerase Chain Reaction | 6 | 2015 | 6085 | 0.070 |
Why?
|
| Dose-Response Relationship, Drug | 5 | 2020 | 10778 | 0.070 |
Why?
|
| Neovascularization, Pathologic | 3 | 2012 | 2634 | 0.070 |
Why?
|
| Sirolimus | 1 | 2014 | 1540 | 0.070 |
Why?
|
| Bromodeoxyuridine | 1 | 2007 | 310 | 0.070 |
Why?
|
| Cyclin-Dependent Kinase 5 | 1 | 2007 | 110 | 0.070 |
Why?
|
| Phospholipids | 1 | 2010 | 787 | 0.070 |
Why?
|
| Adenoma | 1 | 2017 | 2164 | 0.070 |
Why?
|
| Cell Movement | 1 | 2018 | 5216 | 0.070 |
Why?
|
| Sensitivity and Specificity | 7 | 2024 | 14751 | 0.070 |
Why?
|
| World Health Organization | 2 | 2023 | 1327 | 0.070 |
Why?
|
| Leukomalacia, Periventricular | 1 | 2008 | 184 | 0.070 |
Why?
|
| Bayes Theorem | 3 | 2023 | 2357 | 0.070 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2014 | 1535 | 0.070 |
Why?
|
| Time Factors | 6 | 2019 | 40266 | 0.070 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2017 | 1672 | 0.070 |
Why?
|
| Monitoring, Intraoperative | 1 | 2013 | 950 | 0.070 |
Why?
|
| Ischemia | 1 | 2015 | 1900 | 0.070 |
Why?
|
| Protein Structure, Tertiary | 1 | 2013 | 3775 | 0.070 |
Why?
|
| Methylation | 2 | 2020 | 1078 | 0.070 |
Why?
|
| HEK293 Cells | 4 | 2022 | 4291 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 2 | 1 | 2007 | 313 | 0.060 |
Why?
|
| Binding Sites | 4 | 2014 | 6023 | 0.060 |
Why?
|
| Feedback, Physiological | 1 | 2008 | 481 | 0.060 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 2015 | 1437 | 0.060 |
Why?
|
| Germ-Line Mutation | 2 | 2017 | 1887 | 0.060 |
Why?
|
| Central Nervous System Fungal Infections | 1 | 2005 | 24 | 0.060 |
Why?
|
| Membrane Glycoproteins | 1 | 2016 | 3714 | 0.060 |
Why?
|
| Quantum Dots | 1 | 2007 | 168 | 0.060 |
Why?
|
| Luciferases | 1 | 2007 | 713 | 0.060 |
Why?
|
| Evidence-Based Medicine | 1 | 2017 | 3709 | 0.060 |
Why?
|
| Genetic Variation | 2 | 2017 | 6610 | 0.060 |
Why?
|
| Contrast Media | 1 | 2018 | 5334 | 0.060 |
Why?
|
| T-Lymphocytes, Regulatory | 2 | 2018 | 3116 | 0.060 |
Why?
|
| Flow Cytometry | 3 | 2017 | 5905 | 0.060 |
Why?
|
| Colonic Neoplasms | 1 | 2017 | 2543 | 0.060 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 2 | 2014 | 1629 | 0.060 |
Why?
|
| Neurodegenerative Diseases | 1 | 2014 | 1094 | 0.060 |
Why?
|
| Immunoblotting | 3 | 2012 | 1647 | 0.060 |
Why?
|
| Leukemia, Myeloid | 1 | 2007 | 693 | 0.060 |
Why?
|
| Proteins | 1 | 2019 | 6011 | 0.060 |
Why?
|
| Brain Abscess | 1 | 2005 | 123 | 0.060 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2007 | 859 | 0.060 |
Why?
|
| Piperazines | 3 | 2009 | 2553 | 0.060 |
Why?
|
| Radiography | 3 | 2014 | 6991 | 0.060 |
Why?
|
| Ectoderm | 1 | 2004 | 138 | 0.060 |
Why?
|
| Genes, Tumor Suppressor | 3 | 2012 | 1064 | 0.060 |
Why?
|
| Genetic Heterogeneity | 2 | 2019 | 737 | 0.060 |
Why?
|
| Diagnostic Imaging | 2 | 2023 | 3538 | 0.060 |
Why?
|
| Wnt Proteins | 2 | 2009 | 725 | 0.060 |
Why?
|
| Blotting, Western | 4 | 2015 | 5035 | 0.060 |
Why?
|
| Transcriptional Activation | 2 | 2022 | 1750 | 0.060 |
Why?
|
| Demyelinating Diseases | 1 | 2006 | 358 | 0.060 |
Why?
|
| Molecular Sequence Data | 8 | 2014 | 17629 | 0.050 |
Why?
|
| Alkaline Phosphatase | 1 | 2006 | 864 | 0.050 |
Why?
|
| Telomere | 2 | 2023 | 943 | 0.050 |
Why?
|
| Hyperargininemia | 1 | 2003 | 12 | 0.050 |
Why?
|
| Claudins | 1 | 2024 | 117 | 0.050 |
Why?
|
| Receptors, AMPA | 1 | 2024 | 335 | 0.050 |
Why?
|
| Endpoint Determination | 2 | 2017 | 594 | 0.050 |
Why?
|
| Wnt1 Protein | 1 | 2003 | 123 | 0.050 |
Why?
|
| Salicylanilides | 1 | 2022 | 15 | 0.050 |
Why?
|
| Galectin 1 | 1 | 2023 | 128 | 0.050 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 2 | 2019 | 550 | 0.050 |
Why?
|
| Patient Selection | 1 | 2014 | 4265 | 0.050 |
Why?
|
| Carrier Proteins | 2 | 2016 | 4940 | 0.050 |
Why?
|
| Prospective Studies | 5 | 2025 | 54950 | 0.050 |
Why?
|
| Tumor Suppressor Protein p14ARF | 1 | 2002 | 84 | 0.050 |
Why?
|
| Open Reading Frames | 2 | 2024 | 818 | 0.050 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2017 | 9081 | 0.050 |
Why?
|
| RNA Interference | 3 | 2019 | 2835 | 0.050 |
Why?
|
| Brain Mapping | 2 | 2016 | 6740 | 0.050 |
Why?
|
| Gene Expression | 2 | 2014 | 7602 | 0.050 |
Why?
|
| Up-Regulation | 4 | 2019 | 4148 | 0.050 |
Why?
|
| Isoenzymes | 1 | 2006 | 1687 | 0.050 |
Why?
|
| Stereotaxic Techniques | 2 | 2016 | 559 | 0.050 |
Why?
|
| Maximum Tolerated Dose | 2 | 2018 | 899 | 0.050 |
Why?
|
| Mesoderm | 2 | 1995 | 679 | 0.050 |
Why?
|
| Computational Biology | 3 | 2020 | 3562 | 0.050 |
Why?
|
| Cardiomyopathies | 1 | 2014 | 2057 | 0.050 |
Why?
|
| bcl-X Protein | 1 | 2023 | 412 | 0.050 |
Why?
|
| Nervous System | 2 | 2022 | 547 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2019 | 1246 | 0.050 |
Why?
|
| Brain Stem | 2 | 2017 | 862 | 0.050 |
Why?
|
| Homozygote | 2 | 2023 | 1779 | 0.050 |
Why?
|
| Genetic Testing | 1 | 2014 | 3590 | 0.050 |
Why?
|
| 5'-Nucleotidase | 1 | 2022 | 164 | 0.050 |
Why?
|
| Consensus | 2 | 2023 | 3214 | 0.050 |
Why?
|
| International Agencies | 2 | 2012 | 244 | 0.050 |
Why?
|
| Drug Therapy, Combination | 3 | 2016 | 6320 | 0.050 |
Why?
|
| High-Throughput Screening Assays | 2 | 2017 | 941 | 0.050 |
Why?
|
| Neurofibromin 1 | 2 | 2012 | 190 | 0.050 |
Why?
|
| Receptor, Notch1 | 1 | 2024 | 520 | 0.050 |
Why?
|
| Protein Binding | 4 | 2014 | 9344 | 0.050 |
Why?
|
| RNA | 2 | 2024 | 2727 | 0.050 |
Why?
|
| Vaccinia virus | 1 | 2022 | 330 | 0.050 |
Why?
|
| Transcription, Genetic | 5 | 2020 | 7609 | 0.050 |
Why?
|
| Motor Neurons | 1 | 2006 | 872 | 0.040 |
Why?
|
| Genetic Markers | 3 | 2015 | 2604 | 0.040 |
Why?
|
| Lipids | 1 | 2011 | 3345 | 0.040 |
Why?
|
| Ki-67 Antigen | 2 | 2016 | 628 | 0.040 |
Why?
|
| Methylnitrosourea | 1 | 2020 | 30 | 0.040 |
Why?
|
| Caspase 3 | 2 | 2016 | 731 | 0.040 |
Why?
|
| Skin Neoplasms | 2 | 2018 | 5864 | 0.040 |
Why?
|
| Mice, Inbred BALB C | 3 | 2014 | 6232 | 0.040 |
Why?
|
| Gene Silencing | 2 | 2020 | 1505 | 0.040 |
Why?
|
| Islets of Langerhans | 1 | 2006 | 1351 | 0.040 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 2 | 2014 | 615 | 0.040 |
Why?
|
| Glutamine | 1 | 2003 | 578 | 0.040 |
Why?
|
| Feedback | 1 | 2023 | 799 | 0.040 |
Why?
|
| Age Factors | 3 | 2024 | 18454 | 0.040 |
Why?
|
| Blood-Brain Barrier | 2 | 2017 | 1036 | 0.040 |
Why?
|
| Genes, Neoplasm | 1 | 2021 | 371 | 0.040 |
Why?
|
| Neurosurgical Procedures | 1 | 2011 | 2110 | 0.040 |
Why?
|
| Transgenes | 1 | 2003 | 1016 | 0.040 |
Why?
|
| Melanoma | 1 | 2018 | 5709 | 0.040 |
Why?
|
| STAT3 Transcription Factor | 2 | 2016 | 875 | 0.040 |
Why?
|
| Collagen Type I | 1 | 2023 | 620 | 0.040 |
Why?
|
| Oncogene Fusion | 1 | 2019 | 84 | 0.040 |
Why?
|
| Abnormalities, Multiple | 1 | 2007 | 1423 | 0.040 |
Why?
|
| Equipment Design | 2 | 2018 | 3529 | 0.040 |
Why?
|
| Cyclin D2 | 1 | 2019 | 98 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-myc | 2 | 2019 | 998 | 0.040 |
Why?
|
| Infant, Newborn | 5 | 2024 | 26394 | 0.040 |
Why?
|
| Cranial Irradiation | 2 | 2015 | 395 | 0.040 |
Why?
|
| Hyperplasia | 2 | 2012 | 1154 | 0.040 |
Why?
|
| Receptors, Antigen, T-Cell | 2 | 2018 | 2574 | 0.040 |
Why?
|
| Random Allocation | 1 | 2023 | 2396 | 0.040 |
Why?
|
| Biphenyl Compounds | 2 | 2014 | 1026 | 0.040 |
Why?
|
| Sequence Deletion | 1 | 2023 | 1498 | 0.040 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2023 | 2475 | 0.040 |
Why?
|
| STAT1 Transcription Factor | 1 | 2020 | 344 | 0.040 |
Why?
|
| Twins | 1 | 2020 | 340 | 0.040 |
Why?
|
| Prosencephalon | 1 | 2020 | 306 | 0.040 |
Why?
|
| Antibodies, Monoclonal | 1 | 2015 | 9264 | 0.040 |
Why?
|
| CDC2 Protein Kinase | 1 | 2019 | 212 | 0.040 |
Why?
|
| Propensity Score | 2 | 2017 | 1968 | 0.040 |
Why?
|
| Organ Specificity | 2 | 2013 | 1970 | 0.040 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2014 | 4064 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinase 7 | 1 | 2018 | 66 | 0.040 |
Why?
|
| S Phase | 1 | 2019 | 424 | 0.040 |
Why?
|
| Tumor Escape | 1 | 2021 | 372 | 0.040 |
Why?
|
| Autocrine Communication | 1 | 2018 | 168 | 0.040 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2023 | 755 | 0.040 |
Why?
|
| DNA Repair | 2 | 2018 | 2054 | 0.040 |
Why?
|
| Diencephalon | 1 | 2017 | 54 | 0.040 |
Why?
|
| Gamma Rays | 1 | 2019 | 319 | 0.040 |
Why?
|
| Proteomics | 2 | 2024 | 3913 | 0.040 |
Why?
|
| Imaging, Three-Dimensional | 3 | 2017 | 4077 | 0.040 |
Why?
|
| Frozen Sections | 2 | 2015 | 154 | 0.040 |
Why?
|
| Lectins, C-Type | 1 | 2021 | 593 | 0.040 |
Why?
|
| Adenosine | 1 | 2022 | 822 | 0.040 |
Why?
|
| Regeneration | 1 | 2006 | 1524 | 0.040 |
Why?
|
| Pregnancy Proteins | 1 | 2018 | 222 | 0.040 |
Why?
|
| Necrosis | 2 | 2015 | 1621 | 0.040 |
Why?
|
| Pilot Projects | 2 | 2024 | 8742 | 0.040 |
Why?
|
| Amino Acid Motifs | 1 | 2019 | 930 | 0.040 |
Why?
|
| Doxorubicin | 1 | 2024 | 2234 | 0.040 |
Why?
|
| Minor Histocompatibility Antigens | 1 | 2018 | 304 | 0.040 |
Why?
|
| Stroke | 1 | 2019 | 9756 | 0.030 |
Why?
|
| Mammals | 1 | 2022 | 1136 | 0.030 |
Why?
|
| Janus Kinase 2 | 1 | 2020 | 560 | 0.030 |
Why?
|
| Histiocytoma, Malignant Fibrous | 1 | 2017 | 54 | 0.030 |
Why?
|
| Receptors, sigma | 1 | 2017 | 46 | 0.030 |
Why?
|
| Peptide Hydrolases | 1 | 2019 | 610 | 0.030 |
Why?
|
| Phosphoserine | 1 | 2017 | 204 | 0.030 |
Why?
|
| Drug Combinations | 1 | 2023 | 2088 | 0.030 |
Why?
|
| Proportional Hazards Models | 3 | 2020 | 12563 | 0.030 |
Why?
|
| Casein Kinase II | 1 | 2017 | 121 | 0.030 |
Why?
|
| Chromogranins | 1 | 2017 | 160 | 0.030 |
Why?
|
| Protein Biosynthesis | 1 | 2024 | 2094 | 0.030 |
Why?
|
| Fibroblasts | 2 | 2023 | 4178 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2023 | 1408 | 0.030 |
Why?
|
| Interferons | 1 | 2020 | 720 | 0.030 |
Why?
|
| Eukaryotic Initiation Factors | 1 | 2016 | 83 | 0.030 |
Why?
|
| Ependyma | 1 | 2016 | 57 | 0.030 |
Why?
|
| Recurrence | 2 | 2019 | 8512 | 0.030 |
Why?
|
| Pyridines | 3 | 2014 | 2896 | 0.030 |
Why?
|
| Drug Interactions | 1 | 2020 | 1421 | 0.030 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 1 | 2019 | 559 | 0.030 |
Why?
|
| Barrett Esophagus | 1 | 2020 | 495 | 0.030 |
Why?
|
| Biopsy | 2 | 2018 | 6805 | 0.030 |
Why?
|
| Cell Count | 2 | 2012 | 1833 | 0.030 |
Why?
|
| Paraplegia | 1 | 2016 | 161 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-raf | 1 | 2016 | 205 | 0.030 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gs | 1 | 2017 | 194 | 0.030 |
Why?
|
| Glycine Dehydrogenase (Decarboxylating) | 1 | 2015 | 15 | 0.030 |
Why?
|
| Pyruvaldehyde | 1 | 2015 | 16 | 0.030 |
Why?
|
| Acetone | 1 | 2015 | 44 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase 4 | 1 | 2019 | 566 | 0.030 |
Why?
|
| Preoperative Period | 1 | 2017 | 565 | 0.030 |
Why?
|
| Mammary Glands, Animal | 1 | 2017 | 273 | 0.030 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2017 | 414 | 0.030 |
Why?
|
| HeLa Cells | 2 | 2011 | 3076 | 0.030 |
Why?
|
| Hippocampus | 1 | 2007 | 3786 | 0.030 |
Why?
|
| Documentation | 1 | 2021 | 917 | 0.030 |
Why?
|
| Anticonvulsants | 1 | 2024 | 1924 | 0.030 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2018 | 794 | 0.030 |
Why?
|
| Chromatiaceae | 1 | 2014 | 5 | 0.030 |
Why?
|
| Intraoperative Period | 1 | 2015 | 513 | 0.030 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2016 | 329 | 0.030 |
Why?
|
| Chromosome Mapping | 3 | 2013 | 4624 | 0.030 |
Why?
|
| Age of Onset | 1 | 2021 | 3346 | 0.030 |
Why?
|
| Tissue Fixation | 1 | 2015 | 245 | 0.030 |
Why?
|
| Adenovirus E1A Proteins | 1 | 2014 | 81 | 0.030 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2016 | 2911 | 0.030 |
Why?
|
| Histone Code | 1 | 2015 | 160 | 0.030 |
Why?
|
| Equipment Failure Analysis | 1 | 2016 | 848 | 0.030 |
Why?
|
| Ubiquitin | 1 | 2019 | 843 | 0.030 |
Why?
|
| Receptors, Somatostatin | 1 | 2014 | 138 | 0.030 |
Why?
|
| Hematoxylin | 1 | 2013 | 61 | 0.030 |
Why?
|
| Embryonic Stem Cells | 2 | 2014 | 1251 | 0.030 |
Why?
|
| Eosine Yellowish-(YS) | 1 | 2013 | 70 | 0.030 |
Why?
|
| Vertebrates | 1 | 1995 | 227 | 0.030 |
Why?
|
| Vascular Endothelial Growth Factor A | 2 | 2019 | 3518 | 0.030 |
Why?
|
| Smad Proteins | 1 | 2014 | 157 | 0.030 |
Why?
|
| Organoids | 1 | 2020 | 745 | 0.030 |
Why?
|
| Nervous System Diseases | 1 | 2004 | 1665 | 0.030 |
Why?
|
| Chromosome Breakpoints | 1 | 2013 | 93 | 0.030 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2017 | 664 | 0.030 |
Why?
|
| DNA Restriction Enzymes | 1 | 2013 | 548 | 0.030 |
Why?
|
| Pyruvate Kinase | 1 | 2015 | 190 | 0.030 |
Why?
|
| Ribosomal Protein S6 Kinases | 1 | 2013 | 203 | 0.030 |
Why?
|
| Genome | 1 | 2021 | 1752 | 0.030 |
Why?
|
| Selection Bias | 1 | 2015 | 360 | 0.030 |
Why?
|
| Risk Assessment | 2 | 2025 | 24330 | 0.030 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2005 | 2831 | 0.030 |
Why?
|
| Plasmalogens | 1 | 2013 | 30 | 0.030 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2018 | 4651 | 0.030 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2020 | 1803 | 0.030 |
Why?
|
| Morbidity | 1 | 2018 | 1757 | 0.030 |
Why?
|
| Myosins | 1 | 1994 | 408 | 0.030 |
Why?
|
| Hormones | 1 | 2017 | 871 | 0.030 |
Why?
|
| Immunophenotyping | 1 | 2018 | 1866 | 0.030 |
Why?
|
| Mediastinal Neoplasms | 1 | 2015 | 403 | 0.030 |
Why?
|
| Fetus | 1 | 2020 | 1882 | 0.030 |
Why?
|
| Melanophores | 1 | 2012 | 16 | 0.030 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2021 | 1813 | 0.030 |
Why?
|
| Ligands | 1 | 2019 | 3283 | 0.030 |
Why?
|
| 3' Untranslated Regions | 1 | 2015 | 515 | 0.030 |
Why?
|
| Cell Hypoxia | 1 | 2015 | 662 | 0.030 |
Why?
|
| MutS Homolog 2 Protein | 1 | 2013 | 200 | 0.030 |
Why?
|
| Transcription Factor AP-1 | 1 | 2014 | 321 | 0.030 |
Why?
|
| Calibration | 1 | 2015 | 823 | 0.030 |
Why?
|
| Nucleic Acid Amplification Techniques | 1 | 2015 | 340 | 0.030 |
Why?
|
| Cytoplasm | 1 | 2017 | 1505 | 0.030 |
Why?
|
| Macaca fascicularis | 1 | 2014 | 913 | 0.030 |
Why?
|
| Microspheres | 1 | 2015 | 789 | 0.030 |
Why?
|
| Color | 1 | 2013 | 297 | 0.030 |
Why?
|
| Oxidation-Reduction | 1 | 2018 | 2226 | 0.030 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2022 | 2892 | 0.030 |
Why?
|
| Gene Library | 1 | 2015 | 1062 | 0.020 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2014 | 440 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 6 | 1 | 2013 | 370 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2016 | 1645 | 0.020 |
Why?
|
| Drug Delivery Systems | 1 | 2023 | 2238 | 0.020 |
Why?
|
| Cerebellum | 1 | 2019 | 1522 | 0.020 |
Why?
|
| Genomic Instability | 1 | 2016 | 715 | 0.020 |
Why?
|
| Phosphatidylinositols | 1 | 2013 | 280 | 0.020 |
Why?
|
| Analysis of Variance | 2 | 2012 | 6242 | 0.020 |
Why?
|
| Steroids | 1 | 2017 | 938 | 0.020 |
Why?
|
| Dimethyl Sulfoxide | 1 | 2012 | 251 | 0.020 |
Why?
|
| Intermediate Filament Proteins | 1 | 2012 | 262 | 0.020 |
Why?
|
| Phosphatidylserines | 1 | 2013 | 186 | 0.020 |
Why?
|
| Killer Cells, Natural | 1 | 2021 | 2211 | 0.020 |
Why?
|
| Neurofibromin 2 | 1 | 2013 | 271 | 0.020 |
Why?
|
| Procarbazine | 1 | 2011 | 172 | 0.020 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2015 | 567 | 0.020 |
Why?
|
| Lomustine | 1 | 2011 | 60 | 0.020 |
Why?
|
| Schwann Cells | 1 | 2012 | 196 | 0.020 |
Why?
|
| Small Molecule Libraries | 1 | 2017 | 742 | 0.020 |
Why?
|
| Coloring Agents | 1 | 2014 | 564 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 9 | 1 | 2013 | 534 | 0.020 |
Why?
|
| Drug Administration Schedule | 2 | 2010 | 4862 | 0.020 |
Why?
|
| Cell Separation | 1 | 2017 | 1728 | 0.020 |
Why?
|
| Hypoxia-Inducible Factor 1 | 1 | 2012 | 193 | 0.020 |
Why?
|
| Genes, erbB-1 | 1 | 2012 | 163 | 0.020 |
Why?
|
| Hypoglycemic Agents | 1 | 2023 | 3110 | 0.020 |
Why?
|
| Cell Nucleolus | 1 | 2011 | 156 | 0.020 |
Why?
|
| Cause of Death | 1 | 2021 | 3721 | 0.020 |
Why?
|
| Radiation Tolerance | 1 | 2013 | 478 | 0.020 |
Why?
|
| Gene Rearrangement | 1 | 2016 | 1148 | 0.020 |
Why?
|
| Muscle, Smooth | 1 | 1994 | 931 | 0.020 |
Why?
|
| Larva | 1 | 2012 | 514 | 0.020 |
Why?
|
| Microglia | 1 | 2019 | 1376 | 0.020 |
Why?
|
| Principal Component Analysis | 1 | 2013 | 948 | 0.020 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2019 | 1893 | 0.020 |
Why?
|
| Remission Induction | 1 | 2016 | 2411 | 0.020 |
Why?
|
| Mice, 129 Strain | 1 | 2011 | 369 | 0.020 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2020 | 1519 | 0.020 |
Why?
|
| United States Food and Drug Administration | 1 | 2018 | 1672 | 0.020 |
Why?
|
| Amino Acid Sequence | 4 | 2012 | 13427 | 0.020 |
Why?
|
| Immunity | 1 | 2015 | 1003 | 0.020 |
Why?
|
| Antigens, CD34 | 1 | 2012 | 656 | 0.020 |
Why?
|
| Esophageal Neoplasms | 1 | 2020 | 1674 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2014 | 1608 | 0.020 |
Why?
|
| Insulin | 1 | 2023 | 6610 | 0.020 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2014 | 847 | 0.020 |
Why?
|
| Immunologic Memory | 1 | 2015 | 1378 | 0.020 |
Why?
|
| Vincristine | 1 | 2011 | 1040 | 0.020 |
Why?
|
| Exons | 1 | 2014 | 2395 | 0.020 |
Why?
|
| Molecular Biology | 1 | 2012 | 573 | 0.020 |
Why?
|
| beta Catenin | 1 | 2014 | 1047 | 0.020 |
Why?
|
| DNA, Complementary | 2 | 2007 | 1990 | 0.020 |
Why?
|
| Oxygen Consumption | 1 | 2015 | 1883 | 0.020 |
Why?
|
| Macrophages | 1 | 2023 | 5800 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2015 | 2635 | 0.020 |
Why?
|
| Calmodulin-Binding Proteins | 1 | 2009 | 239 | 0.020 |
Why?
|
| Blotting, Northern | 1 | 2010 | 1553 | 0.020 |
Why?
|
| O(6)-Methylguanine-DNA Methyltransferase | 1 | 2008 | 83 | 0.020 |
Why?
|
| Canada | 1 | 2013 | 2129 | 0.020 |
Why?
|
| Osteogenesis | 1 | 1995 | 1295 | 0.020 |
Why?
|
| RNA, Neoplasm | 1 | 2010 | 751 | 0.020 |
Why?
|
| Sulfonamides | 2 | 2008 | 1982 | 0.020 |
Why?
|
| Codon | 1 | 2009 | 599 | 0.020 |
Why?
|
| Li-Fraumeni Syndrome | 1 | 2009 | 117 | 0.020 |
Why?
|
| Plant Lectins | 1 | 2008 | 103 | 0.020 |
Why?
|
| Lymphocyte Activation | 1 | 2018 | 5505 | 0.020 |
Why?
|
| Doxycycline | 1 | 2010 | 349 | 0.020 |
Why?
|
| Endostatins | 1 | 2008 | 168 | 0.020 |
Why?
|
| Kidney | 2 | 2019 | 7057 | 0.020 |
Why?
|
| Carcinoma, Embryonal | 1 | 2007 | 36 | 0.020 |
Why?
|
| Fluorescent Dyes | 1 | 2015 | 1933 | 0.020 |
Why?
|
| Plasmids | 1 | 2012 | 2269 | 0.020 |
Why?
|
| Thrombospondins | 1 | 2008 | 196 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2015 | 4042 | 0.020 |
Why?
|
| Aging | 1 | 2006 | 8765 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2018 | 5323 | 0.020 |
Why?
|
| Fibroblast Growth Factors | 1 | 2013 | 873 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2013 | 2862 | 0.020 |
Why?
|
| Homeostasis | 1 | 2018 | 3348 | 0.020 |
Why?
|
| Phosphoproteins | 1 | 2016 | 2452 | 0.020 |
Why?
|
| Diverticulitis | 1 | 2010 | 187 | 0.020 |
Why?
|
| Observer Variation | 1 | 2013 | 2623 | 0.020 |
Why?
|
| Vimentin | 1 | 2008 | 257 | 0.020 |
Why?
|
| Pluripotent Stem Cells | 1 | 2014 | 810 | 0.020 |
Why?
|
| ras Proteins | 1 | 2012 | 1058 | 0.020 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2014 | 1942 | 0.020 |
Why?
|
| Disease Management | 1 | 2017 | 2537 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 2020 | 7860 | 0.020 |
Why?
|
| Europe | 1 | 2013 | 3441 | 0.020 |
Why?
|
| Oligonucleotide Probes | 1 | 2007 | 417 | 0.020 |
Why?
|
| Receptors, Growth Factor | 1 | 2007 | 326 | 0.020 |
Why?
|
| Case-Control Studies | 2 | 2019 | 22294 | 0.020 |
Why?
|
| Streptozocin | 1 | 2006 | 190 | 0.020 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 2008 | 283 | 0.020 |
Why?
|
| Evolution, Molecular | 1 | 2015 | 1894 | 0.020 |
Why?
|
| Seminoma | 1 | 2007 | 136 | 0.020 |
Why?
|
| Chromosomes, Artificial, Bacterial | 1 | 2006 | 125 | 0.020 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2008 | 594 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2009 | 1755 | 0.020 |
Why?
|
| Microdissection | 1 | 2005 | 151 | 0.020 |
Why?
|
| Protein Conformation | 1 | 2013 | 3956 | 0.020 |
Why?
|
| Receptor, erbB-2 | 1 | 2016 | 2606 | 0.020 |
Why?
|
| DNA Primers | 1 | 2009 | 2827 | 0.020 |
Why?
|
| Radiotherapy Dosage | 1 | 2012 | 2920 | 0.020 |
Why?
|
| Nucleic Acid Hybridization | 1 | 2006 | 1305 | 0.020 |
Why?
|
| Environmental Exposure | 1 | 2020 | 4538 | 0.010 |
Why?
|
| Lectins | 1 | 2006 | 490 | 0.010 |
Why?
|
| Neutropenia | 1 | 2010 | 893 | 0.010 |
Why?
|
| Adipokines | 1 | 2006 | 309 | 0.010 |
Why?
|
| Skin | 1 | 2018 | 4507 | 0.010 |
Why?
|
| Mutation, Missense | 1 | 2014 | 2592 | 0.010 |
Why?
|
| Organ Size | 1 | 2009 | 2268 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2021 | 10397 | 0.010 |
Why?
|
| Species Specificity | 1 | 2009 | 2419 | 0.010 |
Why?
|
| Radiotherapy | 1 | 2011 | 1506 | 0.010 |
Why?
|
| Amino Acid Substitution | 1 | 2009 | 1741 | 0.010 |
Why?
|
| Integrases | 1 | 2006 | 520 | 0.010 |
Why?
|
| Lymph Nodes | 1 | 2015 | 3473 | 0.010 |
Why?
|
| Benzamides | 1 | 2009 | 1387 | 0.010 |
Why?
|
| Biomedical Research | 1 | 2019 | 3463 | 0.010 |
Why?
|
| Retroperitoneal Neoplasms | 1 | 2007 | 335 | 0.010 |
Why?
|
| Rhabdomyosarcoma | 1 | 2006 | 358 | 0.010 |
Why?
|
| Amino Acids, Basic | 1 | 2003 | 9 | 0.010 |
Why?
|
| United States | 3 | 2018 | 73180 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-met | 1 | 2007 | 567 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2014 | 8200 | 0.010 |
Why?
|
| Data Interpretation, Statistical | 1 | 2013 | 2714 | 0.010 |
Why?
|
| Survivors | 1 | 2014 | 2383 | 0.010 |
Why?
|
| Models, Molecular | 1 | 2013 | 5404 | 0.010 |
Why?
|
| DNA | 1 | 2017 | 7214 | 0.010 |
Why?
|
| Brain Ischemia | 1 | 2016 | 3008 | 0.010 |
Why?
|
| Arginase | 1 | 2003 | 81 | 0.010 |
Why?
|
| Learning | 1 | 2012 | 1761 | 0.010 |
Why?
|
| Animals, Genetically Modified | 1 | 2007 | 1564 | 0.010 |
Why?
|
| Thalidomide | 1 | 2008 | 886 | 0.010 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2008 | 1073 | 0.010 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2010 | 1126 | 0.010 |
Why?
|
| Adenocarcinoma | 1 | 2020 | 6401 | 0.010 |
Why?
|
| Motor Activity | 1 | 2012 | 2722 | 0.010 |
Why?
|
| Ammonia | 1 | 2003 | 248 | 0.010 |
Why?
|
| Transformation, Genetic | 1 | 2002 | 194 | 0.010 |
Why?
|
| Transfection | 1 | 2010 | 5763 | 0.010 |
Why?
|
| Thrombocytopenia | 1 | 2010 | 1181 | 0.010 |
Why?
|
| Reactive Oxygen Species | 1 | 2009 | 2149 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2015 | 12093 | 0.010 |
Why?
|
| Transplantation, Heterologous | 1 | 2010 | 2395 | 0.010 |
Why?
|
| Infusion Pumps, Implantable | 1 | 2002 | 158 | 0.010 |
Why?
|
| Research Design | 1 | 2017 | 6213 | 0.010 |
Why?
|
| Carcinoma, Basal Cell | 1 | 2006 | 565 | 0.010 |
Why?
|
| Pedigree | 1 | 2009 | 4545 | 0.010 |
Why?
|
| Apolipoproteins E | 1 | 2006 | 1461 | 0.010 |
Why?
|
| Heart | 1 | 2014 | 4448 | 0.010 |
Why?
|
| Neoplasm Metastasis | 1 | 2011 | 4926 | 0.010 |
Why?
|
| Models, Neurological | 1 | 2009 | 1783 | 0.010 |
Why?
|
| RNA, Small Interfering | 1 | 2009 | 3433 | 0.010 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2009 | 2433 | 0.010 |
Why?
|
| Endothelium, Vascular | 1 | 2012 | 4428 | 0.010 |
Why?
|
| Retroviridae | 1 | 2002 | 849 | 0.010 |
Why?
|
| Luminescent Proteins | 1 | 2002 | 839 | 0.010 |
Why?
|
| Arginine | 1 | 2003 | 932 | 0.010 |
Why?
|
| Sex Factors | 1 | 2013 | 10641 | 0.010 |
Why?
|
| Gene Regulatory Networks | 1 | 2007 | 1752 | 0.010 |
Why?
|
| Pediatrics | 1 | 2014 | 3628 | 0.010 |
Why?
|
| Pregnancy | 1 | 2020 | 30175 | 0.010 |
Why?
|
| Prevalence | 1 | 2015 | 15875 | 0.010 |
Why?
|
| Positron-Emission Tomography | 1 | 2014 | 6673 | 0.010 |
Why?
|
| Oxygen | 1 | 2009 | 4273 | 0.010 |
Why?
|
| Pyrazoles | 1 | 2008 | 2029 | 0.010 |
Why?
|
| Risk Factors | 2 | 2015 | 74971 | 0.010 |
Why?
|
| Myogenic Regulatory Factors | 1 | 1996 | 102 | 0.010 |
Why?
|
| Renal Dialysis | 1 | 2003 | 1789 | 0.010 |
Why?
|
| Connective Tissue | 1 | 1995 | 425 | 0.010 |
Why?
|
| Mice, Inbred Strains | 1 | 1995 | 1769 | 0.010 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 1993 | 767 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 1995 | 4168 | 0.010 |
Why?
|
| Liver | 1 | 2003 | 7579 | 0.000 |
Why?
|
| Muscle, Skeletal | 1 | 1996 | 4980 | 0.000 |
Why?
|